Page 12 of 14 SEC Filing (ii) Shared power to vote or to direct the vote
See Cover Pages Items 5-9.
(iii) Sole power to dispose or to direct the disposition of
See Cover Pages Items 5-9.
(iv) Shared power to dispose or to direct the disposition of
See Cover Pages Items 5-9.
Item 5. Ownership of Five Percent or Less of a Class.
Not Applicable. Item 6. Ownership of More than Five Percent on Behalf of Another Person.
Partners, BVF Inc. and Mr. Lampert share voting and dispositive power over the shares of Common Stock beneficially owned by BVF, BVF2, Trading Fund OS, and the Partners Management Accounts. Item 7. Identification and Classification of the Subsidiary That Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable. Item 8. Identification and Classification of Members of the Group.
See Exhibit 99.1 to Amendment No. 2 to Schedule 13G filed with the Securities and Exchange Commission on February 16, 2016. Item 9. Notice of Dissolution of Group.
Not Applicable. Item 10. Certifications.
By signing below each of the undersigned certifies that, to the best of its knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. Follow Cytokinetics Inc (NASDAQ:CYTK)
Follow Cytokinetics Inc (NASDAQ:CYTK)
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
| | (ii) | Shared power to vote or to direct the vote |
| | See Cover Pages Items 5-9. |
| | (iii) | Sole power to dispose or to direct the disposition of |
| | See Cover Pages Items 5-9. |
| | (iv) | Shared power to dispose or to direct the disposition of |
| | See Cover Pages Items 5-9. |
| Item 5. | Ownership of Five Percent or Less of a Class. |
Not Applicable.
| Item 6. | Ownership of More than Five Percent on Behalf of Another Person. |
Partners, BVF Inc. and Mr. Lampert share voting and dispositive power over the shares of Common Stock beneficially owned by BVF, BVF2, Trading Fund OS, and the Partners Management Accounts.
| Item 7. | Identification and Classification of the Subsidiary That Acquired the Security Being Reported on by the Parent Holding Company or Control Person. |
Not Applicable.
| Item 8. | Identification and Classification of Members of the Group. |
See Exhibit 99.1 to Amendment No. 2 to Schedule 13G filed with the Securities and Exchange Commission on February 16, 2016.
| Item 9. | Notice of Dissolution of Group. |
Not Applicable.
| Item 10. | Certifications. |
By signing below each of the undersigned certifies that, to the best of its knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
Follow Cytokinetics Inc (NASDAQ:CYTK)
Follow Cytokinetics Inc (NASDAQ:CYTK)
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
